Intra Cellular Therapies shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Intra Cellular Therapies shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intra Cellular Therapies by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $602k | 8.4k | 71.62 |
2019-06-30 | $324k | 26k | 12.71 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies